The Cigna Group (CI) Revenue — Quarter Ended Jun 30, 2023
Revenue for the quarter increased compared to both the immediately preceding quarter and the same quarter one year earlier. The company’s management discussion and analysis provides context for the reported performance.
Key takeaway
Quarter ended Jun 30, 2023 · FY2023 Q2
Revenue for the quarter increased compared to both the immediately preceding quarter and the same quarter one year earlier. The company’s management discussion and analysis provides context for the reported performance.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$48.6B
Revenue reported for this quarter.
Quarter-over-quarter
+4.4%
Change from the immediately preceding quarter.
Year-over-year
+6.8%
Change from the comparable year-ago quarter.
Trailing four quarters
$186.1B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2022 | $45.3B | +2.2% |
| Dec 31, 2022 | $45.8B | +0.2% |
| Mar 31, 2023 | $46.5B | +5.7% |
| Jun 30, 2023 | $48.6B | +6.8% |
Revenue performance
Total revenues rose, driven by higher pharmacy revenues, premiums, and fees and other revenues. Net income attributable to shareholders was lower than the same quarter a year ago.
Quarterly comparison
Compared with the prior quarter, revenue was higher, extending the upward trend seen in recent quarters. Relative to the same quarter one year earlier, revenue also showed an increase.
What to watch
The company’s risk factors and management discussion sections offer further detail on the drivers of revenue and expense changes.